Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Scientist predicts stem cell 'pharmacies'

Press Association,John von Radowitz
Monday 12 July 2010 10:28 BST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Stem cell "pharmacies" that dispense tissue therapies could be as common as chemist shops in 20 years' time, according to a top scientist.

Professor David Warburton, one of the world's leading experts on stem cells and regenerative medicine, said the era of stem cell technology was only just beginning.

In two decades he expected it to yield undreamed-of forms of personalised treatment for damaged body parts and organs.

Speaking on the eve of a major stem cell meeting in Nottingham, he said: "In about 20 years' time we will have stem cell banks just like we now have pharmacies with medicines in them.

"You'll get a diagnosis for a specific problem and be given stem cells to treat that problem."

Stem cells are "mother" cells that can be grown in the laboratory and used to make replacement tissue, such as brain neurons or insulin-producing pancreas cells.

Those obtained from early stage embryos - embryonic stem cells (ESCs) - have the ability to become virtually any kind of tissue in the human body.

Use of human embryos in research creates ethical concerns. However recent developments have led to ways of "tweaking" the genes of ordinary cells to turn them into stem cells with ESC-like properties.

Such research, combining genetics with regenerative medicine, has enormous potential, Prof Warburton believes.

"It's a wonderful time to be working in medical research," he said. "Genomic research is going to apply stem cell research not only to a specific disease but to a specific person with a disease. You're going to have personalised regenerative medicine."

Prof Warburton is based at the Saban Research Institute of the Children's Hospital, Los Angeles.

He has pioneered research into the use of stem cells extracted from the amniotic fluid that surrounds a baby in the womb.

Currently Prof Warburton is working towards clinical trials of kidney treatments using amniotic stem cells.

"These cells go around the circulation, sniff out the damage, and change the milieu inside the kidney," he said.

Scientists at his laboratory are also looking at reconstructing lungs using stem cells - a feat that has already been achieved in animals.

Other developments that might soon produce benefits include experimental stem cell treatments for blood diseases and spinal cord injuries, said Prof Warburton.

The UK National Stem Cell Network annual meeting is taking place in Nottingham all this week.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in